Clinical trial
Umbilical Cord Mesenchymal Stem Cell Infusion With Liraglutide in Type 2 Diabetes Mellitus
NCT01954147 is registered in ClinicalTrials.gov with Diabetes Care Center of Nanjing Military Command as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Umbilical Cord Mesenchymal Stem Cell Infusion With Liraglutide in Type 2 Diabetes Mellitus
- Lead sponsor
- Diabetes Care Center of Nanjing Military Command
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- October 31, 2013
- Completion date
- October 31, 2015
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes